✦ LIBER ✦

Phase I clinical trials of WR-2721 with alkylating agent chemotherapy

✍ Scribed by John H. Glick; Donna J. Glover; Clare Weiler; Albert Blumberg; Diana Nelson; John M. Yuhas; Morton Kligerman

Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 710 KB
Volume: 8
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(82)90687-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials of WR-2721 with radiatio

Clinical trials of WR-2721 with radiation therapy

✍ Albert L. Blumberg; Diana F. Nelson; Mary Gramkowski; Donna Glover; John H. Glic 📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Phase I Controlled trials of WR-2721 and

Phase I Controlled trials of WR-2721 and cyclophosphamide

✍ John H. Glick; Donna Glover; Clare Weiler; Lorraine Norfleet; John Yuhas; Morton 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 506 KB

Phase I trials of WR-2721 and cis-platin

Phase I trials of WR-2721 and cis-platinum

✍ Donna Glover; John H. Glick; Clare Weiler; John Yuhas; Morton M. Kligerman 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 477 KB

Phase I trials of WR2721 in combination

Phase I trials of WR2721 in combination with radiation therapy and with the alkylating agents cyclophosphamide and cis-platinum

✍ Morton M. Kligerman; John H. Glick; Harold I. Amols; John M. Yuhas 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Phase I/II trials of WR-2721 and cis-pla

Phase I/II trials of WR-2721 and cis-platinum

✍ Donna Glover; John H. Glick; Clare Weiler; Kevin Fox; Andrew Turrisi; Morton M. 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Topical application of WR-2721 to preven

Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A phase I/II trial

✍ Gusfavo S. Montana; Mitchell S. Anscher; Charles M. Mansbach II; Nicolas Duly; M 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

Patients undergoing x-ray therapy to the pelvis have intestinal symptoms proportional to the volume treated and the dose delivered. WR-2721, S-2 (3-aminopropylaminoethyl) phosphorothioic acid, is an organic thiophosphate compound that selectively protects normal tissues against radiation effects. A